Production (Stage)
Celularity Inc.
CELU
$1.76
$0.010.57%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 95.05% | -23.24% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 95.05% | -23.24% | |||
| Cost of Revenue | 89.11% | 82.90% | |||
| Gross Profit | 99.32% | -45.80% | |||
| SG&A Expenses | 26.94% | -20.48% | |||
| Depreciation & Amortization | 0.27% | -17.76% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 32.57% | -6.56% | |||
| Operating Income | 17.82% | -13.29% | |||
| Income Before Tax | 17.42% | -148.12% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 17.42% | -148.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 17.42% | -148.12% | |||
| EBIT | 17.82% | -13.29% | |||
| EBITDA | 21.14% | -17.78% | |||
| EPS Basic | 18.59% | -146.72% | |||
| Normalized Basic EPS | 20.42% | -149.21% | |||
| EPS Diluted | 18.59% | -146.72% | |||
| Normalized Diluted EPS | 20.42% | -149.21% | |||
| Average Basic Shares Outstanding | 1.44% | 0.58% | |||
| Average Diluted Shares Outstanding | 1.44% | 0.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||